Dr. O’Connor is a Professor of Medicine and Chief of the Section of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. Dr. O’Connor’s research and scholarly work have focused on the interface between primary care and substance abuse. He has written well over 100 papers on these topics and has been published in leading medical journals including The New England Journal of Medicine and JAMA. Dr. O’Connor’s work in the area of opiate detoxification led to research examining the efficacy of opioid maintenance therapy in treating heroin dependence in primary care settings. He and his colleagues at Yale completed a series of studies that look at the effectiveness of methadone and of buprenorphine as the pharmacological agent for this treatment in primary care settings. He has begun to examine the use of buprenorphine in patients with HIV disease. Among his accomplishments as Chief of General Internal Medicine at Yale is the recruitment of several academic “generalist” faculty to join efforts to perform research on the identification and treatment of substance use disorders in medical settings. The overall goal is to improve access for patients with substance usedisorders to high quality care for their substance use disorders in the context of their general medical care.
Dr. Sokol is Distinguished Professor of Obstetrics and Gynecology and holds the John M. Malone, Jr. M.D. Endowed Chair and Directorship of the C.S. Mott Center for Human Growth and Development and the Wayne State University School of Medicine/Detroit Medical Center, where he also served as Department Chair for six years, as well as Dean and Senior Vice President for Medical Affairs for 11 years. Among other honors, he was elected President of the Society for Maternal-Fetal Medicine, the Central Association of Obstetricians and Gynecologists, the Detroit Medical Academy and the Wayne State University Academy of Scholars. He chaired the Liaison Committee for Obstetrics and Gynecology and is Editor-in-Chief of ACOG Update, a monthly CME publication. Dr. Sokol has published extensively on the prevention of perinatal brain damage, particularly as it relates to prenatal exposure to alcohol and cocaine. His honors include many national research awards, a lifetime achievement award from the Society of Maternal-Fetal Medicine and awards from the Wayne State University School of Medicine student body, alumni and school. Dr. Sokol has authored more than 1,300 publications, including 300 referenced papers. He serves on four boards of directors of professional theaters, two of which he has chaired, is a vice chair of the board of a medical school, the American University of the Caribbean, and serves on many other boards and committees.
Dr. Samet is a graduate of Brandeis University and Baylor College of Medicine. He trained in Internal Medicine at Boston City Hospital, Boston University School of Medicine (BUSM), and in a research fellowship at the Massachusetts General Hospital. He has been a primary care physician in Boston since 1983. Dr. Samet is a Professor of Medicine at Boston University School of Medicine and Professor of Social and Behavioral Sciences at the Boston University School of Public Health. In 2002, he became the Chief of General Internal Medicine at BUSM/Boston Medical Center and Vice Chair for Public Health in the Department of Medicine. Dr. Samet has a longstanding commitment to educating physicians about substance use disorders. Since 1995, he has served as Medical Director of Substance Abuse Prevention and Treatment Services for the Boston Public Health Commission. He also has been President of the Association of Medical Education and Research in Substance Abuse (1999- 2001), co-chair of the Substance Abuse Task Force of the Society of General Internal Medicine (1992-2002), and a member of the Institute of Medicine Committee on “Addressing the Quality Chasm in Mental Health and Addictive Disorders.” Dr. Samet also has chaired the ASAM Medical-Scientific Annual Conference Program Committee for the past four years.
Dr. D’Onofrio is Professor and Chair of the Department of Emergency Medicine, Yale University School of Medicine. In that post, she maintains an active clinical practice in addition to her teaching and research responsibilities. Dr. D’Onofrio is one of only a handful of Emergency Medicine specialists funded as a principal investigator for multiple R01 grants by the National Institutes of Health. Dr. D’Onofrio’s efforts as an educator include the development of a structured curriculum to teach Emergency Medicine specialists about screening and brief intervention (SBI) for alcohol problems. The curriculum, which employs a teaching video and skill-based practice scenarios, has been accepted by the Society of Academic Medicine and incorporated into a toolkit distributed to all emergency practitioners by the American College of Emergency Physicians. Dr. D’Onofrio also is a co-investigator on an NIH multi-center trial entitled “National Alcohol Screening Day and Academic Emergency Medicine Department Collaborative Study.” She also has helped develop the national strategic plan for training all health professionals in SBI, funded by HRSA, AMERSA, and SAMHSA. Dr. D’Onofrio is a member of the NIAAA advisory board for National Alcohol Screening Day, has received a NIDA grant for training chief residents in all disciplines, and her educational curriculum and teaching tools have been utilized throughout the United States and Canada.
Dr. Hays graduated from medical school at the University of Kentucky in 1982 then pursued residency training at the University of Kentucky, which he completed in 1986. At that time he joined the faculty in the Department of Psychiatry. In addition to being Board Certified by the American Board of Psychiatry and Neurology, Dr. Hays also is certified by the American Society of Addiction Medicine and has Added Qualifications in both Addiction Psychiatry and Geriatric Psychiatry. He completed a Certificate of Medical Management in 1998 and went on to obtain his M.B.A. from the University Of Kentucky Gatton School Of Business in May 2001. Dr. Hays’ research interests include Opioid dependence and other aspects of addiction. Dr. Hays has served as Chairman of Psychiatry since 1998. He is the Director of Area V of the American Academy of Addiction.
Dr. Adger is Professor of Pediatrics at the Johns Hopkins University School of Medicine and Director of Adolescent Medicine at the Johns Hopkins Hospital, which he joined in 1984. Since that time, he has served as Director of the Substance Abuse Assessment/Intervention Team at The Johns Hopkins Hospital Adolescent Program and as Director of The Johns Hopkins Substance Abuse Faculty Development Programs. In February 1997, Dr. Adger was selected to fill the position of Deputy Director of the White House Office of National Drug Control Policy. In July 1998, he returned to Johns Hopkins to resume his duties as a full-time faculty member. From 1999-2005, he served as Co-Director of the Strategic Planning Initiative funded by HRSA and SAMHSA/CSAT to advise the federal government and others on improving and expanding interdisciplinary education and training of health professionals in substance use disorders. He currently serves as principal investigator and project director of the HRSA-funded Leadership & Education in Adolescent Health project at the Johns Hopkins Hospital and as the faculty leader of the Florence Sabin College in the Johns Hopkins School of Medicine. Dr. Adger also is a past president of the Association for Medical Education and Research in Substance Abuse and a past president of the National Association for Children of Alcoholics.
Dr. Baxter is the President and CEO of the Professional Assistance Program of New Jersey that manages impaired healthcare professionals. He is also the Medical Director for the Division of Addiction Services in the State of New Jersey Department of Human Services, and the Immediate Past-President of the American Society of Addiction Medicine. Dr. Baxter completed his undergraduate degrees in Biology and American Civilization at the University of Pennsylvania and earned his Medical Doctorate at Temple University School of Medicine. Dr. Baxter completed his Internship and residency training in Internal Medicine at UMDNJ Cooper Hospital University Medical Center. He sub-specialized in Addiction Medicine through training at Portsmouth Psychiatric Hospital. Dr. Baxter is an Associate Clinical Professor of Medicine at the University of Medicine & Dentistry New Jersey in Newark New Jersey. He is Immediate Past President of the American Society of Addiction Medicine and serves on the Board of Directors. He has also been appointed to the Board of Directors of the National Association of Drug Court Professionals. He has served on a number of National Advisory Councils and Committees which include, SAMSHA, CSAT, NIDA, and the FDA. He is a member of many other medical organizations and has many publications.
Dr. Blondell received his medical degree from the University of Rochester School of Medicine and Dentistry in 1978, completed a Family Practice residency at the University of Louisville in 1981 and successfully fulfilled the certification requirements of the American Board of Family Medicine in 1981 (he was recertified in 1987, 1993, 1999 and 2005). After two years of full-time clinical practice in Rochester, Dr. Blondell began a career in academic medicine at Marshall University, in Huntington, WV. He returned to the University of Louisville in 1985, where he served as the Program Director of the Family Practice Residency from 1989 to 1997. After a sabbatical in 1998, when he successfully fulfilled the certification requirements for the American Society of Addiction Medicine, he established and directed an Addiction Medicine consult service at the University of Louisville Hospital from 1998 until he moved to Buffalo in 2003 to assume the post of Professor in the Department of Family Medicine at the State University of New York at Buffalo, School of Medicine and Biomedical Sciences, where he also maintains an active research portfolio.
Dr. Brady is a Professor of Psychiatry at the Medical University of South Carolina (MUSC), where she also is Director of the Clinical Neuroscience Division. In 2005, she was appointed Assistant Dean for Clinical Research and Director of the MUSC General Clinical Research Center. She also is the Principal Investigator and Director of the Southern Consortium of the NIDA Clinical Trials Network and the Principal Investigator and Center Director for one of eleven Specialized Centers for Research on Sex and Gender Factors Affecting Women’s Health. Reflecting Dr. Brady’s special interest in co-occurring psychiatric and substance use disorders and the pharmacotherapy of substance use disorders, her research has had a special focus on victimization and post-traumatic stress disorder, particularly the cooccurrence of anxiety and affective disorders in substance-using women. She also studies the interface between basic and clinical science and the translation of empirically-based treatments from academic medical centers to front-line treatment settings. Dr. Brady is a past President of the Association for Medical Education and Research in Substance Abuse (1994-1996), and of the American Academy of Addiction Psychiatry (2003-2005). She directed the MUSC Addiction Psychiatry Fellowship Program from 1994-2004 and has served as a mentor for a number of post-doctoral Fellows, residents and junior faculty.
Dr. Friedmann is a s Professor of Medicine, Health Services, Policy and Practice at the Alpert Medical School and School of Public Health at Brown University, and directs the Research Section in the Division of General Internal Medicine at Rhode Island Hospital and the Center on Systems, Outcomes & Quality in Chronic Disease & Rehabilitation, a center for health services research at the Providence VA Medical Center. He is a primary care internist, addiction medicine clinician, and established substance abuse health services researcher who has published widely on the organization of treatment services, treatment process and outcomes and the role of the medical and criminal justice systems in the management of substance use disorders. Dr. Friedmann is PI of the Rhode Island Research Center of NIDA’s Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) program and as such he was lead investigator of Step’n Out, a six-site, randomized trial of integrated community supervision and outpatient addiction treatment for drug-dependent parolees. He currently chairs the CJ-DATS workgroup on medication-assisted treatment. He is also Rhode Island site PI of a five-site trial of depot naltrexone for opioid-dependent ex-offenders. Dr. Friedmann is a Fellow of the American Society of Addiction Medicine and the immediate past president of the Association of Medical Education and Research in Substance Abuse (AMERSA). He has been a Diplomate of the American Board of Internal Medicine since 1991, ASAM-certified since 1998, and was a member of the first group of ABAM Diplomates. He also serves as Associate Editor of the Journal of Substance Abuse Treatment and on the Editorial Board of Internal Medicine News, a forum he frequently use to champion addiction medicine among internists.
Dr. Gentilello attended Albert Einstein School of Medicine (1982), and completed a residency in general surgery at the University of Texas School Of Medicine in Houston. He also completed a fellowship in surgical critical care at the University of Texas, and a fellowship in trauma surgery at the University of Miami. Dr. Gentilello joined the faculty of the University of Washington School Of Medicine in 1990, where his research focused on injury prevention and public health and has been supported by continuous external funding by federal and other agencies. Dr. Gentilello has been the Chairman of the Division of Burns, Trauma and Critical Care at UT Southwestern Medical School, and holder of the C. James Carrico MD Distinguished Chair in Surgery for Trauma and Critical Care. He has published over 200 articles, textbook chapters and abstracts. In recognition of his research on alcohol as a risk factor for injuries, Dr. Gentilello received an Innovators Combating Substance Abuse Award from the Robert Wood Johnson Foundation, and from the American Society of Addiction Medicine, for expanding the Frontiers of the Field of Addiction Medicine and Broadening our Understanding of the Addiction Process through Research and Innovation.
Dr. Miller is Associate Clinical Professor, University of Wisconsin School of Medicine and Public Health, and Medical Director, Herrington Recovery Center Rogers Memorial Hospital. He is board certified in general psychiatry and addiction psychiatry and in addiction medicine by the American Board of Addiction Medicine. He is a Fellow of the American Psychiatric Association (APA) and the American Society of Addiction Medicine (ASAM). Dr. Miller has published a number of articles, editorials, and guest commentaries, authored chapters for ASAM’s textbook, Principles of Addiction Medicine. Dr. Miller earned his MD from Tulane University Medical Center in 1979 and a BS, Psychology from Georgetown. He served as national President of the American Society of Addiction Medicine (ASAM) from 2007 through 2009. He represents the ASAM at the AMA’s Physician Consortium for Performance Improvement. Dr. Miller was elected Vice Speaker of the House of Delegates of the Wisconsin Medical Society in 2009. He holds associate clinical professorships in the Departments of Psychiatry, Family Medicine, and Internal Medicine at the University of Wisconsin School of Medicine and Public Health.
Dr. Nunes, Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons, is an expert in treatment of patients with substance dependence and co-occurring psychiatric disorders. Following study at Dartmouth College (A.B. in Psychology and Chemistry) and University of Connecticut School of Medicine (M.D.), he completed his residency and a research fellowship in clinical psychopharmacology at the New York State Psychiatric Institute. He has authored over 100 book chapters and articles in peer-reviewed journals and currently serves as principal investigator and mentor/consultant on multiple NIH-funded studies that examine a variety of treatments (i.e., medication, behavioral, and psychotherapeutic approaches) for substance dependence and related psychiatric disorders. His ongoing studies examine treatment of cocaine dependence, heroin and other opioid dependence, and substance dependence co-occurring with psychiatric disorders, including depression and post-traumatic stress disorder. He is a Principal Investigator in the National Institute on Drug Abuse (NIDA) Clinical Trials Network. Dr. Nunes serves as Chair of the Treatment Research Review Committee at NIDA and serves on the Board of Directors of the College on Problems of Drug Dependence. He has been a long-time member of the New York State Psychiatric Institute/Columbia University Department of Psychiatry IRB and now serves as Vice Chairman of the IRB.
Dr. Wilkins is the Lincy/Heyward-Moynihan Chair of Addiction Medicine at Cedars-Sinai Medical Center where he also directs the ACGME approved Fellowship in Addiction Psychiatry. Dr. Wilkins has initiated addiction medicine related programs at CSMC including screening of all new inpatients for the risk of alcohol withdrawal. He has also supported the identification of alcohol dependence in patients admitted for trauma surgery and screening for the presence of opioid dependence in patients scheduled for surgery. Dr. Wilkins’ research interests include pharmacotherapy of patients with alcohol and/or substance abuse problems including with co-occurring mental illness. He has investigated treatment outcome of homeless veterans with substance abuse problems. This research received funding from the National Institute on Drug Abuse, the National Institute of Mental Health and the Veterans Administration. Dr. Wilkins is also evaluating innovative techniques in substance abuse prevention in adolescents and children. A board-certified psychiatrist, Dr. Wilkins is a diplomate of the American Board of Medical Examiners and the American Board of Psychiatry and Neurology, from which he has also received added qualifications in addiction psychiatry. He is a Distinguished Fellow of the American Psychiatric Association and is a Fellow of, and certified by, the American Society of Addiction Medicine. He has written articles for numerous peer-reviewed publications and serves as a reviewer for numerous journals. Dr. Wilkins sits on numerous boards, including the California Society of Addiction Medicine (as President), the Brent Shapiro Foundation for Drug Awareness, and the Psychological Trauma Center.
Dr. Wunsch received her M.D. degree from the Uniformed Services University School of Medicine and completed residency training in Pediatrics and a fellowship in Addiction Medicine at Virginia Commonwealth University. She currently heads an addiction clinic in Blacksburg, VA. She has served was an Associate Professor at the University of Kentucky in the Department of Behavioral Sciences and the Center on Drug and Alcohol Research. Her clinical and research interests are focused upon rural prescription drug abuse. She is a Physician Clinical Support System mentor to doctors across Appalachia providing office-based buprenorphine treatment.